| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/29/2002 | US20020119156 Polynucleotides and polypeptides which are diagnostic markers for lung cance |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119143 Antithrombin III for disorders caused by angiogenesis |
| 08/29/2002 | US20020119142 Therapy and prophylaxis of metastasis of cancer cells by administering angiotensin |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 08/29/2002 | DE10106970A1 Neues Benzoylguanidinsalz New Benzoylguanidinsalz |
| 08/29/2002 | CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | CA2698079A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2473197A1 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy |
| 08/29/2002 | CA2451089A1 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | CA2442742A1 Quinazoline derivatives |
| 08/29/2002 | CA2438775A1 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | CA2438769A1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | CA2438754A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2438711A1 Tryptase inhibitors |
| 08/29/2002 | CA2438709A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 08/29/2002 | CA2438685A1 Tryptase inhibitors |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2438610A1 Treatment of refractory tumors using epothilone derivatives |
| 08/29/2002 | CA2438598A1 Epothilone derivatives for the treatment of refractory tumors |
| 08/29/2002 | CA2438519A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | CA2438504A1 Treatment of solid tumours with rapamycin derivatives |
| 08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | CA2438312A1 Anthrone derivatives and their use as jnk inhibitors |
| 08/29/2002 | CA2437989A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/29/2002 | CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | CA2426659A1 Method for treatment of tumors using combination therapy |
| 08/28/2002 | EP1234879A2 Human nucleic acid sequences from prostate tumour tissue |
| 08/28/2002 | EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 08/28/2002 | EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234585A2 Methods and compositions for the prevention or treatment of cancer |
| 08/28/2002 | EP1234583A1 PEG-conjugates of HGF-NK4 |
| 08/28/2002 | EP1234578A2 Antitumor and antiviral medications and method for producing the same |
| 08/28/2002 | EP1234575A1 Furan fatty acids for improving the efficiency of cytostatic and/or radiation therapy |
| 08/28/2002 | EP1234188A2 Protein kinase regulation |
| 08/28/2002 | EP1234185A2 Pin1 as a marker for abnormal cell growth |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234041A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234033A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233981A1 G-protein coupled receptor |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233969A2 Mono- and disaccharide derivatives |
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233958A1 Inhibitors of histone deacetylase |
| 08/28/2002 | EP1233956A1 Bryostatin analogues, synthetic methods and uses |
| 08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 08/28/2002 | EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS |
| 08/28/2002 | EP1233948A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 08/28/2002 | EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 08/28/2002 | EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/28/2002 | EP1233787A1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233774A1 Urotensin-ii analogs |
| 08/28/2002 | EP1233773A1 Mixture of pomegranate seed oil and juice products |
| 08/28/2002 | EP1233770A2 Phosphonate compounds |
| 08/28/2002 | EP1233769A1 Novel compounds |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | EP1077720B1 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
| 08/28/2002 | EP1021438A4 Trioxane dimer compounds having antiproliferative and antitumor activities |
| 08/28/2002 | EP0988300B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 08/28/2002 | EP0973731B1 Hydroxamic acid derivatives |
| 08/28/2002 | EP0912192B1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 08/28/2002 | EP0806956B1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment |
| 08/28/2002 | EP0800387B1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 08/28/2002 | EP0794966B1 Humanized antibodies to cd38 |
| 08/28/2002 | EP0794961B1 Lhrh antagonist peptides |
| 08/28/2002 | CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1366040A Recombinant virus of human vascular endothelial growth inhibitor |
| 08/28/2002 | CN1365973A New cycloheplene compound, its preparation method and medicine composition containing same |
| 08/28/2002 | CN1365809A Nano medicine 'Fuke Tongjing' and its preparing process |
| 08/28/2002 | CN1365784A Chinese herbal medicine for treating cancer |
| 08/28/2002 | CN1365773A Nano medicine 'Niuhuang Qianjin' and its preparing process |
| 08/28/2002 | CN1365693A Nano medicine for treating cervical cancer and its preparing process |
| 08/28/2002 | CN1365668A Active centipede extract for suppressing cancer and its extracting process |
| 08/28/2002 | CN1365665A Synergistic composition containing ascobic acid salt and lysine used for diseases related with extracellular substrate degeneration |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089763C Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 08/28/2002 | CN1089761C Sidechain-bearing texanes and its preparing process |
| 08/28/2002 | CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 08/28/2002 | CN1089755C Distamycin derivatives, processe for preparing them, and their use as antitumor and antiviral agents |
| 08/28/2002 | CN1089600C Medicine for treating leukemia |
| 08/28/2002 | CN1089583C Mycophenolate mofetil high dose oral suspensions |
| 08/28/2002 | CN1089582C Agent for slow releasing medicine |